US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Chervon North America Recalls EGO Power+ Cordless Brushless Hedge Trimmers Due to Laceration Hazard

      The rear switch trigger can fail to rebound after being pressed, which can cause the unit to activate unexpectedly, posing a laceration hazard. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch

April 11, 2022 By The FDA Leave a Comment

Summary

Company Announcement Date:
April 12, 2022
FDA Publish Date:
April 12, 2022
Product Type:
Drugs

Reason for Announcement:

Recall Reason Description

Label may be missing on some vials

Company Name:
Mylan Pharmaceuticals, Inc. a Viatris Company
Brand Name:

Brand Name(s)

Product Description:

Product Description

Insulin Glargine (Insulin glargine-yfgn) Injection


Company Announcement

FOR IMMEDIATE RELEASE – PITTSBURGH – April 12, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargine- yfgn) Injection, 100 units/mL (U-100), which is packaged in a 10 mL vial that is inside a carton. This product is not the branded Semglee vial but the unbranded Insulin Glargine- yfgn vial. This batch is being recalled due to the potential for the label to be missing on some vials. The product information, batch number and expiry date information are present on the carton.

This batch was manufactured by Biocon Sdn. Bhd. and was distributed by Mylan Specialty L.P. in the US between December 9, 2021, and March 4, 2022. The recalled batch is as follows:

NDC # Name and Strength Size Batch# Expiry
49502-393-80 Insulin Glargine (Insulin glargine-yfgn)
Injection, 100 units/mL (U-100)
10 mL vial BF21002800 Aug 2023

Risk Statement: For patients receiving treatment with more than one type of insulin (e.g., both short and long-acting insulin), a missing label on Insulin Glargine vials could lead to a mix-up of products/strengths, which may result in less optimal glycemic control (either high or low blood sugar) which could result in serious complications. To date, no adverse events related to this recall have been received for this product.

This recall does not pertain to the branded interchangeable biosimilar, Semglee® (insulin glargine-yfgn) injection but to the unbranded interchangeable biosimilar Insulin Glargine-yfgn vial.

The product is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

The company has initiated the recall of batch BF21002800 and notified its distributors and retailers by letter and is arranging for return of all recalled products. Following are actions for wholesalers, retailers and consumers:

  • Wholesaler: Immediately examine your inventory, quarantine, and discontinue distribution of the batch subject to recall. In addition, if you have further distributed the product, please identify all customers, including retail level customers, and provide a list of customers via Microsoft excel file to [email protected] within 5 business days. Sedgwick (Stericycle) will notify your retail level customers that received the affected batch.
  • Retailer: Immediately examine your inventory, quarantine, and discontinue distribution of this batch.
  • Consumer: If you have an unlabeled product, please contact Stericycle at 1-888-912-7084 for the documentation packet to return product to Stericycle.

Consumers with questions regarding this recall can contact Viatris Customer Relations by 1-800-796-9526 or [email protected], Monday through Friday from 8 a.m. – 5 p.m. EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris’ portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 37,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.

Contacts:

Media:

+1.724.514.1968
[email protected]

Jennifer Mauer
[email protected]

Matt Klein
[email protected]

Investors:

+1.724.514.1813
[email protected]

Bill Szablewski
[email protected]


Company Contact Information


Product Photos

  • Labeling, Insulin Glargine Injection
  • Labeling, Box, Insulin Glargine Injection

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Chervon North America Recalls EGO Power+ Cordless Brushless Hedge Trimmers Due to Laceration Hazard

May 31, 2023 By The CPSC

Jetson Electric Bikes Recalls Nova and Star 3-Wheel Kick Children’s Scooters Due to Fall Hazard

May 31, 2023 By The CPSC

Empower Brands Recalls Power XL Self-Cleaning Juicers Due to Laceration and Ingestion Hazards

May 31, 2023 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Cricket Creek Farm Recalls Sophelise and Tobasi Cheeses Because of Potential Listeria Monocytogenes Contamination

May 30, 2023 By The FDA

A.S.K. Foods Inc. Issues Allergy Alert on Undeclared Milk In Wegmans Penne Rigate Mozzarella Salad

May 25, 2023 By The FDA

T.W. Garner Food Company Issues Voluntary Recall on Texas Pete® Buffalo Wing Sauce Due to Undeclared Soy

May 24, 2023 By The FDA

Bunch Bikes Recalls The Preschool Electric Bicycles Due to Violation of the Federal Lead Paint Ban; Lead Poisoning Hazard (Recall Alert)

May 24, 2023 By The CPSC

The Good and the Beautiful Recalls Math 1 and Math 3 Boxes Due to Laceration Hazard (Recall Alert)

May 24, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Bunch Bikes Recalls The Preschool Electric Bicycles Due to Violation of the Federal Lead Paint Ban; Lead Poisoning Hazard (Recall Alert)

May 24, 2023 By The CPSC

The Good and the Beautiful Recalls Math 1 and Math 3 Boxes Due to Laceration Hazard (Recall Alert)

May 24, 2023 By The CPSC

Juratoys Recalls Children’s Activity Tables Due to Choking Hazard

May 24, 2023 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Chervon North America Recalls EGO Power+ Cordless Brushless Hedge Trimmers Due to Laceration Hazard
  • Jetson Electric Bikes Recalls Nova and Star 3-Wheel Kick Children’s Scooters Due to Fall Hazard
  • Empower Brands Recalls Power XL Self-Cleaning Juicers Due to Laceration and Ingestion Hazards
  • Rudolph Foods Issues Allergy Alert on Undeclared Wheat in Rudolph’s OnYums “Onion Flavored Rings”, 3 oz. Packages
  • Tillamook Issues Allergy Alert on Undeclared Wheat and Soy in Tillamook Waffle Cone Swirl Ice Cream Packaged in Chocolate Peanut Butter Ice Cream Carton
  • Cricket Creek Farm Recalls Sophelise and Tobasi Cheeses Because of Potential Listeria Monocytogenes Contamination
  • A.S.K. Foods Inc. Issues Allergy Alert on Undeclared Milk In Wegmans Penne Rigate Mozzarella Salad
  • T.W. Garner Food Company Issues Voluntary Recall on Texas Pete® Buffalo Wing Sauce Due to Undeclared Soy
  • Bunch Bikes Recalls The Preschool Electric Bicycles Due to Violation of the Federal Lead Paint Ban; Lead Poisoning Hazard (Recall Alert)
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in